Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Although there is evidence to link schizophrenia (SCZ) and bipolar disorder (BD) to genetic and environmental factors, specific individual or groups of genes/factors causative of the disease have been elusive to the research community. An understanding of the molecular aberrations that cause these mental illnesses requires comprehensive approaches that examine both genetic and epigenetic factors. Because of the overwhelming evidence for the role of environmental factors in the disease presentation, our initial approach involved deciphering how epigenetic changes resulting from promoter DNA methylation affect gene expression in SCZ and BD. Apparently, the central reversible but covalent epigenetic modification to DNA is derived from methylation of the cytosine residues that is potentially heritable and can affect gene expression and downstream activities. Environmental factors can influence DNA methylation patterns and hence alter gene expression. Such changes can be especially problematic in individuals with genetic susceptibilities to specific diseases. Recent reports from our laboratory provided compelling evidence that both hyper- and hypo-DNA methylation changes of the regulatory regions play critical roles in defining the altered functionality of genes in major psychiatric disorders such as SCZ and BD. In this chapter, we outline the technical details of the methods that could help to expand this line of research to assist with compiling the differential methylation-mediated epigenetic alterations that are responsible for the pathogenesis of SCZ, BD, and other mental diseases. We use the genes of the extended dopaminergic (DAergic) system such as membrane-bound catechol-O-methyltransferase (MB-COMT), monoamine oxidase A (MAOA), dopamine transporter 1 (DAT1), tyrosine hydroxylase (TH), dopamine (DA) receptors1 and 2 (DRD1/2), and related genes (e.g., reelin [RELN] and brain-derived neurotrophic factor [BDNF]) to illustrate the associations between differential promoter DNA methylations and disease phenotype. It is our hope that comprehensive analyses of the DAergic system as the prototype could provide the impetus and molecular basis to uncover early markers for diagnosis, help in the understanding of differences in disease severity in individuals with similar or identical genetic makeup, and assist with the identification of novel targets for therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238 · cited 2×
“2 ml mineral oil and under aluminum foil to avoid evaporation and light exposure (35).”
BackgroundDNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 1×
“This process is often mediated by c-AMP and cyclic AMP response element binding protein (CREB) which as a consequence could also alter promoter/regulatory DNA methylation status and expression of the affected gene (13-16).”
BackgroundDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030718 · Cited by 574
Reelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462 · cited 5×
“We have extensively used bisulfite treated genomic DNA sequencing and MSP (32) to map the differentially methylated CpG islands in the promoter regions of the RELN, DRD2 and COMT genes in psychiatric disorders (27, 28).”
BackgroundMethodSelf-citationCortical Abnormalities in Schizophrenia Identified by Structural Magnetic Resonance Imaging
Goldstein, J. M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.537 · Cited by 369
Huang, Y.-Y., Simpson, E., Kellendonk, C., & Kandel, E. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308280101 · Cited by 231 · cited 2×
“This process is often mediated by c-AMP and cyclic AMP response element binding protein (CREB) which as a consequence could also alter promoter/regulatory DNA methylation status and expression of the affected gene (13-16).”
BackgroundAbdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216
Self-citation
Cited by
Prospects for epigenetic epidemiology
Foley, D. L., Craig, J. M., Morley, R., Olsson, C. J., Dwyer, T., Smith, K., & Saffery, R. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn380 · Cited by 244
Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
Abdolmaleky, H. M., Yaqubi, S., Papageorgis, P., Lambert, A. W., Ozturk, S., Sivaraman, V., & Thiagalingam, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.007 · Cited by 192
Self-citationNohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Self-citationAbdolmaleky, H. M., Nohesara, S., Ghadirivasfi, M., Lambert, A. W., Ahmadkhaniha, H., Ozturk, S., Wong, C. K., Shafa, R., Mostafavi, A., & Thiagalingam, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.007 · Cited by 102
“Quantitative methylation specific PCR (qMSP) was employed to assess the degree of CpG methylation of 5-HTT promoter using previously described methods (Abdolmaleky et al., 2008) using the primers listed in Table 3.”
Self-citationCerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile
Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., et al. (2012) · Scientific Reports · doi:10.1038/srep00667 · Cited by 76
Metadata
- Authors
- Abdolmaleky, H. M., Smith, C. L., Zhou, J.-R., & Thiagalingam, S.
- Venue
- Methods in Molecular Biology™
- Publisher
- Humana Press
- Published
- 2008
- Volume
- 448
- Pages
- 187-212
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W95948130
- Cited by
- 74
- References
- 10
- FWCI
- 10.95
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders. https://app.cochat.ai/papers/10.1007/978-1-59745-205-2_9
- The paper
- Abdolmaleky, H. M., Smith, C. L., Zhou, J.-R., & Thiagalingam, S. (2008). Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders. Methods in Molecular Biology™. https://doi.org/10.1007/978-1-59745-205-2_9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.